A prophylactic effect of an oligodeoxynucleotide containing a cytidineguanosine motif against Japanese cedar pollen-induced t-helper type 2 allergic response

Journal of Asthma

Volumn 48, Issue 9, 2011, Pages 974-978

  Liu, Beixing ^a,b   Zhang, Leiying ^a   Liu, Jing ^a   Shan, Fengping ^a   Wang, Enhua ^a   Kimura, Yoshinobu ^b,c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF FUKUI   (Japan)

^c GIFU UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Allergic airway inflammation; BALB c mice; Japanese cedar pollen (JCP); Oligodeoxynucleotide containing a cytidine guanosine motif (CpG ODN); Th1 Th2 type responses

Indexed keywords

ALLERGEN; CPG OLIGODEOXYNUCLEOTIDE; EOSIN; HEMATOXYLIN; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; INOCULATION; JAPANESE CEDAR; MALE; MOUSE; NONHUMAN; POLLEN ALLERGY; QUANTITATIVE ANALYSIS; REVIEW; SENSITIZATION; TH2 CELL;

ALLERGENS; ANIMALS; CRYPTOMERIA; CYTIDINE; DINUCLEOSIDE PHOSPHATES; GUANOSINE; MALE; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; POLLEN; RESPIRATORY HYPERSENSITIVITY; TH2 CELLS;

EID: 80054891927     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2011.619288     Document Type: Review

References (25)

1. Beasley R, Crane J, Lai CK, Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 2000; 105:S466-S472
2. Pauwels R. The relationship between airway inflammation and bronchial hyperresponsiveness. Clin Exp Allergy 1989; 19: 395-398
3. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161:1720-1745
4. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105:651-653
5. Renz H, Bradley K, Saloga J, Loader J, Larsen GL, Gelfand EW. T cells expressing specific V? elements regulate immunoglobulin E production and airways responsiveness in vivo. J Exp Med 1993; 177:1175-1180
6. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17:255-281
7. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000; 105:399-408
8. Krieg AM, Matson S, Fisher E. Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs. Antisense Nucleic Acid Drug Dev 1996; 6:133-139
9. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20:709-760
10. Kline JN, Kitagaki K, Businga TR, Jain VV. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am J Physiol 2002; 283:L170-L179
11. Jain VV, Businga TR, Kitagaki K, George CL, OShaughnessy PT, Kline JN. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am J Physiol 2003; 285:L1137-L1146
12. Burger MS, Zuleger CL, Chu Q, Gao X, Payne LG, Chen D. An antigen-independent but not antigen-specific TH1 response provides protection in the murine airway inflammation model. J Allergy Clin Immunol 2004; 114:1301-1308
13. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV. Modulation of airway inflammation by CpG oligonucleotides in a murine model of asthma. J Immunol 1998; 160:2555-2559
14. Agrawal DK, Edwan J, Kandimalla ER, Yu D, Bhagat L. Novel immunomodulatory oligonucleotides(IMOs) prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma. Int Immuno Pharmacol 2004; 4:127-138
15. Liu B, Kimura Y. Respiratory syncytial virus protects against the subsequent development of Japanese cedar pollen-induced allergic responses. J Med Virol 2007; 79:1600-1605
16. Kovarik J, Bozzotti P, Love-Homan L, Pihlgren M, Davis HL, Lambert PH, Krieg AM, Siegrist CA. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J Immunol 1999; 162:1611-1617
17. Sur S, Wild JS, Choudhury BK, Sur N, Alam R, Klinman DM. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999; 162: 6284-6293
18. Jahn-Schmid B, Wiedermann U, Bohle B, Repa A, Kraft D, Ebner C. Oligodeoxynucleotides containing CpG motifs modulate the allergic Th2 response of BALB/c mice to Bet v 1, the major birch pollen allergen. J Allergy Clin Immunol 1999; 104:1015-1023
19. Kips JC, Brusselle GG, Joos GF, Peleman RA, Devos RR, Tavernier JH, Pauwels RA. Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int Arch Allergy Immunol 1995; 107:115-118
20. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, Bluethmann H. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allerg 1994; 24:6-9
21. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-793
22. Linden A, Adachi M. Neutrophilic airway inflammation and IL-17. Allergy 2002; 57:769-775
23. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108:430-438
24. Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, Boulet LP, Hamid Q. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003; 111:1293-1298
25. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, Mathieu C, Ceuppens JL. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003; 28:42-50